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Polymer surface and biological fluids

The surface (physics/chemistry) differs from the bulk

Core bulk

surface

• Surface energies are different than bulk
• Surface reactivities are different than bulk
• Surface properties are different than bulk

Defining and Characterizing Interfaces

What’s so special about a surface?

Surface phenomena are driven by a reduction in
surface (free) energy.

Biomaterials surfaces are sites of:
- adsorption of a species from the environment
- surface segregation of a species from the bulk of
biomaterial
- surface reconstructions/re-organization
- surface reactions

Define “Surface”
What information do you want?

• In most cases, cells and proteins, microorganisms respond to outer atomic layers (~3nm)

or first few monolayers) of surface
• Spatial resolution of method

• Topographical information
• Gradient between surface and bulk

Lots of expensive toys and tools for analysis
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No one technique does it all!!
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A single technique will provide an answer …..
but it might not be the correct answer!

Heuristics and algorithms to provide ideas
Biomedical Surface Analysis
full characterization of complex surfaces

Surface Properties

Biological Performance

Materials Science
synthesis of complex surfaces

Cell & Molecular Biology
Biological structure & activity

What is your surface?

atactic? syndiotactic, isotactic?

For biomedical applications, it’s complicated……

Surface mobility and re-arrangement
air

water

Reorientation of polymer chains: water versus air (PDMS)

Demonstrating polymer mobility using XPS
Ratner et. al. J. Appl. Polymer Sci. 22 643 (1978)

Radiation grafted layers of poly(HEMA) and polyacrylamide
(>1 µm thick) on silicone rubber core

graft
layer

CH3
-(Si-O)n-

CH3

silicone rubber

Silicone rubber (PDMS)

ESCA examination at room temperature showed only PDMS?

Initial XPS spectra under vacuum looked like pure
silicone rubber

• Silicone rubber: hydrophobic – likes air
• PHEMA: hydrophilic doesn’t like air or vacuum

Binding Energy (eV)

Install a cold stage on the ESCA/XPS instrument

Frozen hydrated samples can be studied

Polymer surface mobility: cold stage XPS/ESCA
Poly(hydroxyethyl methacrylate)
grafted to silicone rubber
(frozen-hydrated, -120 deg. C.)

Poly(hydroxyethyl methacrylate)
grafted to silicone rubber
(dry air - ambient temperature)
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same study done with an acrylamide graft (reversal seen); also grafted on polyethylene (no reversal)
Ratner,BD; et al., (1978): Radiation-grafted hydrogels for biomaterial applications as studied by the
ESCA technique. J. Appl. Polym. Sci. 22, 643-664.

Polymer surface mobility by ESCA
Ratner et al., J. Appl. Polym. Sci. 22, 643-664

Considerations for this study
1. Vacuum pumping on frozen samples (particularly
with ion pumps)
2. Molecular mobility and glass transition temperature
of polymers (also, did the grafted layer migrate into
water or did the silicone migrate into air?)
3. Penetration depth and graft layer thickness

More polymer mobility: hydrogels

Sum Frequency
Generation (SFG)
technique

A. Opdahl et al., J.
Phys. Condensed
Matt., 16(21) (2004).

Surface contamination

clean

contaminated

Common lab surface-active agents = ubiquitous surface contaminants

Glassware, pump oil

silicones

phthalates

adsorbed contaminant overlayers

t= seconds-minutes

https://imageserv5.team-logic.com/mediaLibrary/99/Outgassing_20of_20Silicone_20Elastomers.pdf

We can see silicon on almost
every surface under XPS,
even when it’s not
supposed to be there!

Ambient phthalates in air are
used to calibrate mass spec
instruments!

Common plasticizing agents
Phthalate esters

1,2-cyclohexane dicarboxylic acid diisononyl ester
Hexamoll DINCH

inert organic materials with high
boiling points and low vapor pressures.
Trimellitic acids/esters
Adipate salts and esters

Mechanism of plasticization
External:
Small molecules that “get between’ polymer chains in amorphous
thermoplastics to disrupt polymer-polymer interactions, lower
Tg, act as lubricants to allow chain motions
Internal:
changing polymerization chemistry (copolymerization) to
introduce polymer chain structures that disrupt chain-chain
interactions and lower Tg. More porous, less cohesive structure,
more flexible. Formable.
Desired Result: eliminate brittle, stiff character, deform at lower
bending or tensile forces, imparting flexibility,

Additive bleed to surfaces:
Small molecule and oligomer additives bleed to polymer film surfaces
• Dyes, antioxidants, plasticizers, fillers, oligomers etc.
Your polymer may not be presenting the surface chemistry you think due to bleed.

additive overlayer

http://www.pvc.org/en/p/propertymodification-of-pvc-products

Münch et al., Chemosphere 202 (2018) 742e749

“Migration behavior of both DEHP and TOTM was slightly, even
though not signiﬁcantly, increased by the anti-coagulation
coating”

PDMS elastomer
bleeds oligoPDMS
continuously to
its surface,
unless extracted
in solvent or
oxidized using
plasma.

Anal Chem 75, 2003 6548

Audiences have limited attention spans

% people paying attention

Initial
optimisim
and
excitement

Audience attention curve
Disillusionment
and
dissatisfaction

Checking
email and
surfing
the web

Trough of
despair

sleeping

Time (minutes)

Eager to
leave

Surface

Biological milieu

Let’s look at protein interfacial behavior:
• non-specific adsorption (all proteins, all surfaces)
• specific immobilization (desired proteins on certain surface
locations)

Protein surface adsorption is a long story with a long history of
study but few technical solutions for serious problems:

Protein Adsorption
• first “observable” event when a surface interacts with biology
• energy-driven dynamic process, dependent on proteins & surface
• mediates subsequent cascades/responses
• clotting
• cell adhesion
• inflammation & wound healing
• adsorbed proteins as signal transduction elements

surface  proteins  cells

Proteins comprise discrete building blocks (amino acids) assembled into hierarchical
structures.

Protein structure also produces interfacial reactivity

• high MW polymers of 20 different amino acids
• 1º structure controls protein 3D structure
• conformation – 3D folded structure

• structure = function
folding controlled by
non-covalent interactions

• electrostatic
• hydrogen bonding
• van der Waals
• hydrophobic
non-covalent interactions also control
protein-surface interactions

Protein Structure Energetics: Stability
A close balance of competing energetics determine protein structure.

Surface and Protein Domains
5-20% of protein amino acids contact the surface

The globular protein model:
dynamic, flexible, hydrated and meta-stable

Proteins are dynamic, moving and elastic structures: respond to local environments

Antibody Immobilization: (lysine-surface reaction)

>80 Lysines
• Mis-oriented biomolecules
contribute to lower signal and
non-specific interactions
orientation

denature

Substrate

• Structural losses (denaturation)
from dehydration and surface
interactions

Which Lys residue finds the surface?

aDsorption, Modes
Adsorption is the process of association of solutes (or the solvent) ONTO a
material interface
Absorption is when the solvent is taken up by the material (inside)

Properties of typical soluble proteins
• Proteins > 8kDa begin to fold and exhibit higher order structure: domains
• Peptides (small chains) vs. proteins (folded larger chains)
• Proteins bury hydrophobic amino acids away into interior of domains - avoid water
• Proteins expose hydrophilic amino acids in their hydration shells facing solutions
• Both energy demands compel proteins to fold and find a local energy minimum
• Membrane spanning proteins (cell channels, receptors) are largely insoluble and
highly hydrophobic: only active in membranes
• Domains are held together by weak forces (H-bonds, acid-base, van der Waals)

• small energy input can disrupt domain structures (shaking, heating,
ultrasonic, electrochemical, surfaces): denaturation = loss of protein bioactivity
• Domains can ‘breathe’ - reversible excursions due to flexible conformations
• Glycosylation (attachment of sugars) renders proteins “sticky” to surfaces
• Balance of unfolding tendency vs. exterior hydration stability plays off on surfaces
• All proteins have some interfacial activity, stability and affinity on surfaces

Overview of Protein Adsorption

Favorable and Irreversible
Protein adsorption is energetically favorable: the slight increase in enthalpy is
more than compensated for by a large decrease in free energy. Increases in the
system’s entropy contribute to adsorption irreversibility.

Entropy of adsorption:
protein and surface dehydration drive adsorption

DS
Structured water
Hydrophobic surface

DGads

(spontaneous)

Energy of interaction:
stable protein and surface hydration hinder adsorption

DGads

(not spontaneous)

DH >>0

DS >0
Stable hydration

https://doi.org/10.1016/j.polymer.2010.08.022

Protein Surface Orientation
Adsorption can confine the
protein to a particular orientation
on the surface

Dynamic rearrangement can
lead to changes in orientation

Orientation can affect protein activity!

Protein adsorption principles: take-home summary

All proteins adsorb:
some irreversibly
(denature)

All surfaces adsorb
proteins: some
more than others

Faraday Discuss., 2016,191, 435-464

Biomaterials-relevance: proteins at surfaces
• > 500 serum proteins, but only a few crystal structures known, more protein
sequences known, and more identified simply as ‘present’ without info on function

• Relatively few studied in competitive adsorption experiments on surfaces
• more is known about single protein adsorption in buffer: relevance to in vivo?
• empirical correlations between surface chemistries, amounts of proteins and in
vivo responses
• Adhesion vs. non-adhesion protein ratios important for cell attachment to surfaces
• High albumin adsorption correlated with low platelet and low macrophage activation
• Hydrophobic surfaces generally adsorb more protein because of favorable gain from
both enthalpy (<0) and entropy (>0 for both protein and surface) [DG = DH - TDS <0 ]
• Hydrophilic surfaces adsorb less proteins because of opposing energy cost for
dehydrating both surfaces to impart adsorption contact -> stable hydration, low protein

• Many hypotheses correlating short-term cause-effect for protein adsorption and
response in vivo, but few long-term correlations are observed --> always inflammation
• To date, no surface chemistry can control types and amounts of proteins

Properties of some major plasma proteins
> 500 soluble serum proteins  all compete for the surface!

Protein type

Plasma
concentration
(mg/ml)

Monomer
Molecular weight
(daltons)

Prealbumin

10 - 40

Albumin

35 - 45

IgG

6 - 17

150,000

Fibrinogen*

2.0 - 4.0

340,000

Fibronectin*

0.26-0.38

250,000 (but dimeric)

54,900
highest
abundance

66,500 Low M.W.

• Mass transfer flux favors high albumin loading on surfaces
• Adhesion proteins have integrin binding sites; **albumin non-adhesive**

Trace Cell-Adhesive Extracellular Matrix (ECM) Proteins
Soluble

Adsorbed/Processed

Recognized by cells

Collagen
Proteoglycans
Structural

Laminin
Fibronectin

Vitronectin
Matricellular

Osteopontin
Tenascin
Thrombospondin
SPARC

Fibronectin (trace ECM, ~450kDa)
Heterodimer

Type III Repeats
RGD Cell Binding Domain

Recognized by cell Integrin
receptor

Surface ‘Selection’ of Proteins from Complex Milieu
• Many clinical and non-clinical samples contain hundreds
of soluble proteins: serum, cells, tissue, ocean water
• All of them will bind to surfaces, some more than others
• Surfaces can select certain proteins more than others:

(A)

vs.

(B)

vs.

©

adsorption

vs.

vs.

• Hydrophobic surfaces often select albumin from serum
• Albumin has no recognition features - used as a ‘blocking agent’ on surfaces
• Challenge to create selective adsorption surfaces

Serum Proteins Surfaces Determine Cell Engagement
Density/Concentration
Fibronectin (Fn) vs Albumin
(Alb)

Conformation

Competition

RGD = Cell
Fibronectin

(Fn)

Fibronectin(Fn) vs Albumin(Alb)

binding
site

Hidden or Denatured

Alb Flux > Fn
Flux

Fn = globular protein

• These events determine cell adhesion to surfaces
• Surface chemistry-dependent protein carpet

Affinity of Alb vs. Fn

Many Cell are Attachment Dependent
differentiation
proliferation

migration
survival
spreading

receptor
attachment

ECM

Gene expression

Cell Substrate Adhesive Interactions
For attachment-dependent cells, essential for:
•Cell Adhesion

•Cell Survival

•Cell Migration

•Cell Matrix Assembly

•Cell Shape

•Gene Expression

•Cell Differentiation

•Mechanosensors

•Cell Proliferation

•

Cells never “see” a bare surface

•

Cells always encounter a protein carpet

XPS surface analysis of TCPS and BPS substrates vs. cell culture

XPS C1s Spectra
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HUVEC culture on (oxidized) TCPS after various
protein pre-adsorption conditions
Fn (3g/ml)

Fn:BSA
(3g/ml:400g/ml)

1% serum

a)
after
6
hour
s

b)
after
24
hour
s

• TCPS promotes cell attachment and spreading with various proteins
• “Gold standard” material for cell-surface interactions

HUVEC culture on hydrophobic PLLA after various
protein pre-adsorption conditions
Fn (3g/ml)

Fn:BSA
(3g/ml:400g/ml)

1% serum

after
6
hour
s

after
24
hour
s

• Cells fail to attach and spread in presence of competing proteins

• Fibronectin alone restores attachment and spreading

HUVEC culture on hydrophobic BPS after various
protein pre-adsorption conditions
Fn (3g/ml)

Fn:BSA
(3g/ml:400g/ml)

1% serum

after
6
hour
s

after
24
hour
s

• hydrophobic polystyrene fails to promote cell attachment
in competitive protein conditions

HUVEC culture on hydrophobic TeflonAF
following various protein pre-adsorption conditions
Fn (3g/ml)

Fn:BSA
(3g/ml:400g/ml)

1% serum

6 hrs
after
plating

24
hrs
after
plating

• Cells fail to attach and spread in presence of competing proteins

• Fibronectin alone restores cell attachment and spreading

Only about 1% of the 311 million tons of plastics, or about 3.1 million tons, go into
healthcare,” said Petzold. And yet, medical plastics get an awful lot of attention.
They punch above their weight because they are subject to “the highest quality
requirements and most stringent regulations. Yes, it’s a tiny market,” said Petzold,
“but it has been a large focus for Borealis.”

Bormed SB815MO was developed for blow-fill-seal applications, such as IV bottles
and ampoules in the medical space. “The material of choice has been LDPE,” said
Petzold, which has all the requisite properties for this application—softness,
transparency and processability—save one: “The material must be sterilized at low
temperatures and, thus, requires longer sterilization cycles.” Random PP copolymer has also been used, and while it withstands high sterilization temperatures,
it also exhibits high stiffness. “So you will have the problem of not being able to
empty all of the IV liquid from the bottle or ampoule,” said Petzold. The solution
developed by Borealis combines the properties of both materials: Bormed
SB815MO is as soft as LDPE and can be sterilized at 121° C, thus allowing short
sterilization cycles, and its transparency matches random PP co-polymers.
Bormed SC876CF was developed for complexly structured primary and secondary
IV packaging, where each layer has its own functionality. Petzold illustrated the level
of complexity in a three-layer film:
•The 20-micron outer layer, made of homo or random PP, must be heat resistant;
•the 130- to 160-micron core layer of soft or random PP must be soft and tough; and
•the 30- to 50-micron sealing layer, random PP or terpolymer, must be transparent
and sealable.
All of the layers must withstand sterilization and retain transparency. All of them also
may contain impact modifiers to a lesser or greater extent, which pouch producers
often require to deliver toughness and softness, especially in the core layer. Impact
modifiers are pricey, and “one way that pouch producers can reduce cost is by
reducing the quantity of impact modifiers,” explained Petzold.
By using Bormed SC876CF for this application, the outer layers do not change, but
the amount of impact modifier used in the core layer can be reduced significantly

J. Satulovsky, M. A. Carignano, I. Szleifer
PNAS 2000 97 (16) 9037-9041; https://doi.org/10.1073/pnas.150236197

Vroman effect

Kinetics vs Thermodynamics
Rate vs Stability, Spontaneity

Biomaterials-relevance: proteins at surfaces
Serum proteins studied most at interfaces:
• The Big Three: Albumin, Immunoglobulin G, Fibrinogen
• (Andrade, Hlady)
• The Big Ten: add trace serum proteins with certain physiological
relevance or abundance:

 a-macroglobulin, fibronectin, apolipoproteins A and E, von
Willebrandt Factor, complement C3b, collagen
• Still, very limited set studied on limited set of materials surfaces
• Let’s look at the Big Three

Biomaterials-relevance: proteins at surfaces
• Protein adsorption from single-component solutions is different from multicomponent solutions

•Isotherms show surface loading behavior for one protein as a function of conc.
• Equilibrium can be attained in minutes --> hours --> days, depending…..
• A typical protein monolayer is disorganized, denatured and about 350 ng/cm2

• Multi-layers can form on top of an initial denatured layer (conc/species dependent)
• In competition, high affinity proteins win equilibrium (high kon, low koff)
• faster (high diffusivity) proteins find surface first (rapid diffusion)

• are displaced later by proteins with higher “sticking coefficients” (affinity)
• this is also concentration and protein dependent (Vroman effect)
• Competition between adsorbed proteins that cells and platelets recognize (adhesion
proteins) and non-adhesion proteins (most) determines tissue/cell response
• Adsorbed proteins ‘signals’ combine with soluble cytokine ‘signals’ in vivo to produce
a ubiquitous acute inflammatory response (might resolve)
• All surfaces adsorb some protein (detection limit ~ 1 ng/cm2 or about 0.3%)

Serum’s most abundant: Human serum albumin

3 domains
66kDa (globular)

40 mg/ml in serum
Size: 3nm x 8nm x 3nm
Stephen Curry et al.
Nature Structural Biology 5, 827 - 835 (1998)

The Antibody: Immunoglobulin G (IgG)
Second-most abundant protein in serum, 160kDa, glycosylated, 10mg/ml in serum

Antigen binding domains

Multi-domain
8 nm ‘thick’

10nm

Complement
binding
domain

10nm

IgG binds on one end to targets, interacts on the other with complement

Fibrinogen: #3 in serum

Globular multi-domain glycoprotein, 440kDa, 2 mg/ml in serum

Fibrinogen: responsible for blood clotting
• fibrinogen cleaves to fibrin monomers
• fibrin is crosslinked by FXIIIa:
--> insoluble gel clot

• fibrin gel entraps platelets and
activates platelets’ integrin (gIIbIIIa)
receptor
• cycle enhanced by platelet degranulation

• Fibrin gel is FDA-approved, used as surgical sealant and gel scaffold for tissue
engineering (Baxter, UVA)
• Fibrinogen deposition on biomaterials is linked to undesired blood coagulation
and macrophage activation (inflammatory response)

